Imatinib plasma levels: correlation with clinical benefit in GIST patients.
| Data(s) |
2010
|
|---|---|
| Identificador |
https://serval.unil.ch/?id=serval:BIB_EF7EF608D142 isbn:1532-1827[electronic], 0007-0920[linking] pmid:20179709 doi:10.1038/sj.bjc.6605584 isiid:000276159900018 http://my.unil.ch/serval/document/BIB_EF7EF608D142.pdf http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_EF7EF608D1429 |
| Idioma(s) |
en |
| Direitos |
info:eu-repo/semantics/openAccess |
| Fonte |
British Journal of Cancer, vol. 102, no. 7, pp. 1198-1199 |
| Palavras-Chave | #Albumins/metabolism; Antineoplastic Agents/blood; Antineoplastic Agents/pharmacokinetics; Dose-Response Relationship, Drug; Gastrointestinal Stromal Tumors/drug therapy; Gastrointestinal Stromal Tumors/genetics; Genotype; Glycoproteins/metabolism; Humans; Piperazines/blood; Piperazines/pharmacokinetics; Pyrimidines/blood; Pyrimidines/pharmacokinetics; Treatment Outcome |
| Tipo |
info:eu-repo/semantics/article article |
